F
$ Value
$20K
Shares
258
Price
$76
Filed
Feb 17
Insider
Name
Lippis Daniel J.
Title
CVP, TAVR
CIK
0002004380
Roles
Officer
Transaction Details
Transaction Date
2026-02-16
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
34,564
Footnotes
These restricted stock units were granted on February 12, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.
Filing Info
Lippis Daniel J.'s History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-06 | EW | M | $60K |
| 2026-04-06 | EW | ▼ | $83K |
| 2026-04-06 | EW | M | $0 |
| 2026-03-11 | EW | M | $60K |
| 2026-03-11 | EW | ▼ | $87K |
| 2026-03-11 | EW | M | $0 |
| 2026-02-22 | EW | F | $34K |
| 2026-02-17 | EW | F | $15K |
| 2026-02-16 | EW | F | $20K |
| 2026-02-12 | EW | A | $0 |
Other Insiders at EW (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
BOBO DONALD E JR
CVP,Strategy/Corp Development
|
— | $4.8M | 2026-04-02 |
|
Ullem Scott B.
CVP, Chief Financial Officer
|
— | $2.1M | 2026-04-09 |
|
Zovighian Bernard J
CEO
|
— | $1.7M | 2026-02-13 |
|
Lippis Daniel J.
CVP, TAVR
|
— | $170K | 2026-04-06 |
|
Dahl Andrew M.
SVP, Corporate Controller
|
— | — | 2026-02-22 |